{"gene":"CD1D","run_date":"2026-06-09T22:57:17","timeline":{"discoveries":[{"year":2007,"finding":"Crystal structure of human NKT TCR complexed with CD1d bound to α-galactosylceramide revealed that the NKT TCR docks parallel to, and at the extreme end of, the CD1d-binding cleft in a lock-and-key interaction with the lipid antigen, with the conserved TCR α-chain making primary contacts with the CD1d-antigen complex.","method":"X-ray crystallography of NKT TCR–CD1d–α-GalCer ternary complex","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with direct molecular detail of docking mode, published in high-impact peer-reviewed journal","pmids":["17581592"],"is_preprint":false},{"year":2013,"finding":"A human Vδ1+ γδ TCR binds CD1d–α-GalCer orthogonally over the A' pocket of CD1d, with the Vδ1-chain and germline-encoded CDR1δ loop dominating CD1d contacts, while the CDR3γ loop determines α-GalCer specificity—a docking mode distinct from type I NKT TCRs.","method":"X-ray crystallography of γδ TCR–CD1d–α-GalCer complex; functional assays with primary γδ T cells","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus functional validation, distinct docking mode established rigorously","pmids":["24076636"],"is_preprint":false},{"year":2004,"finding":"Microsomal triglyceride transfer protein (MTP), residing in the endoplasmic reticulum, associates with CD1d in hepatocytes and is required for CD1d-mediated glycolipid antigen presentation; conditional deletion of Mttp in hepatocytes redistributes CD1d expression and abolishes invariant NKT cell activation.","method":"Co-immunoprecipitation, conditional hepatocyte-specific Mttp knockout mice, siRNA silencing in intestinal epithelial cells, in vivo NKT activation assays","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, multiple genetic models (conditional KO, siRNA), functional readout replicated across cell types and labs","pmids":["15107843"],"is_preprint":false},{"year":2005,"finding":"MTP directly transfers phospholipids (but not triglycerides) onto recombinant CD1d in vitro, functioning as an ER chaperone that loads endogenous lipids onto nascent CD1d; chemical inhibition of MTP lipid transfer reduces CD1d-mediated presentation of α-GalCer and endogenous antigens in dendritic cells.","method":"In vitro lipid transfer assay with purified MTP and recombinant CD1d; pharmacological MTP inhibition; siRNA knockdown; MHC class II presentation control","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro reconstitution assay plus orthogonal genetic/pharmacological approaches, replicating findings from PMID:15107843","pmids":["16087713"],"is_preprint":false},{"year":1999,"finding":"Soluble mouse and human CD1d molecules bind α-galactosylceramide at neutral pH as measured by surface plasmon resonance; CD1d can also bind non-antigenic β-GalCer and phosphatidylethanolamine, indicating broad lipid-binding capacity. The orientation of the galactose head group is more critical for TCR contact than for CD1d binding.","method":"Surface plasmon resonance binding assay, in vitro antigen presentation with plate-bound soluble CD1d, purified recombinant CD1d proteins","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct quantitative binding assay (SPR) with reconstituted soluble molecules, first quantitative analysis of monomeric lipid–CD1d interaction","pmids":["10523605"],"is_preprint":false},{"year":2011,"finding":"Crystal structure (2.3 Å) of an autoreactive NKT TCR–phosphatidylinositol–CD1d complex revealed that NKT TCR autoreactivity is mediated by a hydrophobic motif in the non-germline-encoded CDR3β loop that promotes self-association with CD1d, while germline-encoded recognition of CD1d is conserved between self- and foreign antigen recognition.","method":"X-ray crystallography; NKT cell functional assays with natural self-antigen-loaded CD1d","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with functional validation, mechanistic basis for autoreactivity defined","pmids":["21376640"],"is_preprint":false},{"year":2011,"finding":"CD1d binds cardiolipin (a tetra-acylated phospholipid) with two alkyl chains buried in the binding groove and two exposed to solvent, as revealed by a 2.3 Å crystal structure of murine CD1d–cardiolipin; this complex stimulates splenic and hepatic γδ T cells to proliferate and secrete IFN-γ and RANTES in a CD1d-restricted manner.","method":"X-ray crystallography of murine CD1d–cardiolipin complex; lipid loading experiments; in vitro and in vivo γδ T cell stimulation assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus functional in vitro and in vivo validation, orthogonal methods","pmids":["21389252"],"is_preprint":false},{"year":2012,"finding":"Human CD1d presenting lysophosphatidylcholine adopts an altered conformation with a shifted α1 helix and open A' pocket compared to glycolipid-loaded CD1d; iNKT TCR binding requires a 7-Å displacement of the LPC headgroup but stabilizes a closed CD1d-LPC conformation, with CDR3α anchoring the TCR footprint.","method":"X-ray crystallography of CD1d–LPC and iNKT TCR–CD1d–LPC complexes; functional iNKT cell assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures of both CD1d-lipid and TCR ternary complex with functional validation","pmids":["22395072"],"is_preprint":false},{"year":2005,"finding":"KSHV MIR proteins (MIR1 and MIR2) downregulate CD1d surface expression by ubiquitinating a unique lysine residue in the CD1d α-chain cytoplasmic tail, triggering endocytosis without accelerated lysosomal degradation, resulting in reduced activation of CD1d-restricted T cells.","method":"Transfection of MIR proteins into uninfected cells; ubiquitination assays; endocytosis assays; T cell activation assays; cytoplasmic tail mutant CD1d constructs","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct mechanistic dissection using mutagenesis of cytoplasmic tail lysine, endocytosis assays, and functional T cell readout","pmids":["15864354"],"is_preprint":false},{"year":2005,"finding":"HIV-1 Nef physically interacts with the cytoplasmic tail of CD1d (requiring the last 6–10 amino acids), reducing CD1d cell surface expression and impairing CD1d-restricted NKT cell activation; tail-deleted CD1d mutants are resistant to Nef-mediated downregulation.","method":"Co-immunoprecipitation of Nef and CD1d; flow cytometry of surface CD1d; cytoplasmic tail deletion mutants; NKT cell activation assay","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus mutagenesis and functional assay, single laboratory","pmids":["15916790"],"is_preprint":false},{"year":2006,"finding":"PPARγ indirectly upregulates CD1d expression in human dendritic cells by inducing retinol/retinal metabolizing enzymes (RDH10 and RALDH2), increasing intracellular all-trans retinoic acid (ATRA) synthesis; ATRA then activates RARα, which directly drives CD1d transcription and enhanced iNKT cell activation.","method":"Gene expression analysis; pharmacological PPARγ activation; enzyme activity assays; RARα pathway dissection; iNKT cell co-culture activation assays","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multi-step pathway dissected with orthogonal methods in single laboratory, functional readout included","pmids":["16982809"],"is_preprint":false},{"year":1999,"finding":"In the absence of β2-microglobulin (β2m), CD1d is expressed on the cell surface as an endoglycosidase-H-sensitive 45 kDa glycoprotein with immature glycosylation, whereas in the presence of β2m, CD1d acquires endoglycosidase-H resistance (48 kDa mature form); β2m association is required for CD1d to transit through the Golgi and acquire mature glycosylation.","method":"Pulse-chase metabolic labeling; endoglycosidase-H and N-glycanase digestion; transfected cell lines with and without β2m; Western blotting","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution with metabolic labeling and glycosylation analysis, rigorous mechanistic dissection","pmids":["10092605"],"is_preprint":false},{"year":1999,"finding":"CD1d is localized to the apical and lateral surfaces of intestinal epithelial cells, with a large apical intracellular pool; both β2m-associated (48–50 kDa) and non-glycosylated β2m-independent (37 kDa) forms are present, with the 37 kDa form specifically on the apical surface.","method":"Confocal laser microscopy; selective apical/basolateral biotin labeling followed by immunoprecipitation; N-glycanase digestion; Western blotting","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by confocal and surface biotinylation with biochemical characterization, single laboratory","pmids":["10221650"],"is_preprint":false},{"year":1996,"finding":"IFN-γ upregulates CD1d mRNA and cell surface protein expression on intestinal epithelial cell lines in a dose- and time-dependent, cytokine-specific manner.","method":"Whole-cell ELISA for surface CD1d; RT-PCR for CD1d mRNA; cytokine-specific controls across multiple epithelial cell lines","journal":"The American journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct quantitative surface and mRNA assays, cytokine specificity controls, replicated across multiple cell lines","pmids":["8760056"],"is_preprint":false},{"year":2003,"finding":"Intestinal lumenal heat shock protein 110 (Hsp110) acts as an autocrine regulator of CD1d surface expression on intestinal epithelial cells, inducing CD1d expression at mRNA and protein levels.","method":"RT-PCR; confocal microscopy; cell surface ELISA; Western blot; biochemical fractionation and identification of Hsp110 from lumenal contents; immunolocalization in vivo","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — identification of specific luminal factor plus multiple orthogonal expression assays, single laboratory","pmids":["12952923"],"is_preprint":false},{"year":2008,"finding":"KSHV lytic replication downregulates CD1d surface expression; viral danger signals (type I IFN, TLR ligands, viruses) selectively increase CD1D mRNA and surface CD1d on human myeloid dendritic cells while decreasing CD1A, CD1B, and CD1E, leading to NKT cell activation with a Th1-like response.","method":"Flow cytometry of CD1d surface expression; RT-PCR quantification of CD1 family mRNAs; NKT cell co-culture activation assays; type I IFN pathway analysis","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal assays (surface expression, mRNA, NKT activation), single laboratory","pmids":["18253929"],"is_preprint":false},{"year":2014,"finding":"Engagement of epithelial CD1d activates STAT3 signaling and drives STAT3-dependent transcription of IL-10, HSP110, and CD1d itself in intestinal epithelial cells; IEC-specific deletion of CD1d (or its regulator MTP) causes severe NKT-cell-mediated colitis, defining a protective epithelial CD1d→STAT3→IL-10 axis.","method":"Conditional IEC-specific gene deletion (CD1d, MTP, IL-10, HSP110); STAT3 activation assays; in vivo colitis models; bone marrow chimeras","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple conditional KO models with defined cellular phenotypes, pathway confirmed by epistasis, replicated across components","pmids":["24717441"],"is_preprint":false},{"year":2007,"finding":"Endoplasmic reticulum stress in steatotic hepatocytes reduces CD1d protein trafficking to the plasma membrane (despite normal CD1d mRNA levels), impairing CD1d-restricted T cell activation and depleting liver NKT cells; tunicamycin-induced ER stress recapitulates these effects in lean mice.","method":"Subcellular fractionation and flow cytometry for surface CD1d; CD1d-restricted T cell activation assays; ob/ob and tunicamycin-treated mouse models","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic link between ER stress and CD1d trafficking, multiple model systems, single laboratory","pmids":["17607300"],"is_preprint":false},{"year":2017,"finding":"Hepatocyte-specific loss of MTP causes defective CD1d function and increases liver iNKT cell numbers due to altered iNKT cell apoptosis; hepatocyte-specific CD1d deletion produces the same phenotype, demonstrating that hepatocyte CD1d controls liver iNKT cell homeostasis.","method":"Conditional hepatocyte-specific MTP and CD1d knockout mice; flow cytometry; apoptosis assays; iNKT-cell-mediated hepatitis model","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent conditional KO models with convergent phenotypes and defined mechanism (altered iNKT apoptosis)","pmids":["28893990"],"is_preprint":false},{"year":2023,"finding":"CD1d crosslinking on hepatocytes induces tyrosine phosphorylation of the CD1d cytoplasmic tail, recruiting and activating JAK2, which then phosphorylates STAT3 to upregulate anti-apoptotic effectors (Bcl-xL, Mcl-1) and reduce cleaved caspase 3/7, protecting hepatocytes from apoptosis independently of NKT cell interactions.","method":"Hepatocyte-specific CD1d overexpression and knockdown; anti-CD1d crosslinking; JAK2 phosphorylation and STAT3 activation assays; in vitro palmitic acid lipotoxicity model; in vivo liver injury models (HFD, MCD diet, Fas agonist, ConA)","journal":"Journal of hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cytoplasmic tail signaling mechanistically dissected with gain- and loss-of-function plus signaling pathway readouts, single laboratory","pmids":["38438948"],"is_preprint":false},{"year":2008,"finding":"Anti-CD1d monoclonal antibody engagement of CD1d on myeloma cells induces caspase-independent cell death associated with Bax overexpression and mitochondrial membrane potential loss; this requires the CD1d cytoplasmic tail but not the tyrosine residue critical for lysosomal sorting.","method":"Anti-CD1d mAb crosslinking; apoptosis/cell death assays; cytoplasmic tail deletion/mutation constructs; Bax expression analysis; mitochondrial membrane potential measurement","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis of cytoplasmic tail plus multiple cell death assays, single laboratory","pmids":["19056691"],"is_preprint":false},{"year":2001,"finding":"CD1d-glycolipid tetramers generated by oxidative refolding chromatography of fully denatured human CD1d and β2m in the presence of synthetic lipids are functional and specific for iNKT cells, enabling ex vivo identification and enumeration of NKT cells in clinical samples.","method":"Oxidative refolding chromatography; tetramer construction; ex vivo flow cytometry staining of peripheral blood and intrahepatic T cells","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of functional CD1d-lipid complexes validated by specific NKT cell staining, methodological paper","pmids":["11248072"],"is_preprint":false},{"year":2019,"finding":"Sphingomyelin occupies the CD1d binding groove as a non-activating endogenous lipid; absence of acid sphingomyelinase (ASM) in mice leads to sphingomyelin accumulation, diminished CD1d-restricted antigen presentation, impaired iNKT cell selection in the thymus, and decreased iNKT cell levels; pharmacological ASM administration restores antigen presentation and iNKT cell levels.","method":"ASM-deficient mouse and human (Niemann-Pick disease) studies; CD1d antigen presentation assays; thymic iNKT selection analysis; pharmacological ASM administration","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — human and mouse genetic models with pharmacological rescue, multiple orthogonal functional readouts","pmids":["31636468"],"is_preprint":false},{"year":2006,"finding":"Retinoic acid receptor α (RARα) signaling directly regulates CD1d expression in human B cells; CD40L activation downregulates CD1d by reducing RARα response gene expression, and RARα agonists reverse this downregulation; BCR activation upregulates CD1c independently of RAR signaling.","method":"Flow cytometry; RARα agonist treatment; B cell activation with CD40L and BCR crosslinking; functional NKT cell cytotoxicity assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway dissected with pharmacological tools and functional validation, single laboratory","pmids":["21451111"],"is_preprint":false},{"year":2015,"finding":"TLR9 activation induces miR-155, which directly targets the 3'-UTR of CD1D mRNA to reduce CD1d expression on B cells; the transcription factor Ets-1 also directly regulates CD1D gene transcription; these mechanisms collectively impair B cell antigen presentation to iNKT cells in SLE.","method":"miRNA target site reporter assays (3'-UTR luciferase); miR-155 overexpression/inhibition; Ets-1 transcription factor binding analysis; flow cytometry; iNKT cell activation assay","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct 3'-UTR targeting validated plus transcriptional regulation, functional readout, single laboratory","pmids":["25929465"],"is_preprint":false},{"year":2016,"finding":"HDAC2 binds to the CD1D promoter; knockdown of HDAC2 increases CD1d mRNA and surface expression, enhancing CD1d-mediated NKT cell antigen presentation; HDAC inhibitors enhance CD1d expression and NKT cell responses to lymphoma partially by relieving HDAC2-mediated repression of CD1D.","method":"ChIP of HDAC2 at CD1D promoter; HDAC2 siRNA knockdown; RT-PCR and flow cytometry for CD1d; NKT cell activation assays; HDAC inhibitor treatment","journal":"Cancer immunology, immunotherapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct chromatin occupancy by ChIP plus functional knockdown, single laboratory","pmids":["27614429"],"is_preprint":false},{"year":2022,"finding":"CD1d controls the internalization of the lipid transporter CD36 in macrophages; CD1d-deficient macrophages show downregulation of lipid metabolic pathways and increased exogenous lipid import via CD36, priming macrophages for enhanced TLR-stimulated cytokine secretion; blocking CD36-mediated lipid uptake restores normal metabolic and immune responses in CD1d-KO macrophages.","method":"CD1d-KO macrophage transcriptomics/metabolomics; CD36 internalization assays; pharmacological CD36 blockade; TLR stimulation cytokine assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with pharmacological rescue plus multiple metabolic readouts, single laboratory","pmids":["36344546"],"is_preprint":false},{"year":2023,"finding":"CD1d ligation on intestinal enterochromaffin (EC) cells activates protein tyrosine kinase Pyk2, which restrains potassium conductance, leading to calcium influx and peripheral serotonin (5-HT) secretion; inhibitory sphingolipids from Bacteroides fragilis repress this 5-HT release via the same CD1d pathway.","method":"iNKT cell–EC cell co-culture; CD1d-blocking antibodies; Pyk2 inhibition; calcium imaging; potassium channel assays; germ-free mouse experiments","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway (CD1d→Pyk2→K+ conductance→Ca2+ influx→5-HT) dissected with pharmacological tools, single laboratory","pmids":["37354904"],"is_preprint":false},{"year":2013,"finding":"CEACAM5 physically interacts with CD1d through its B3 domain on intestinal epithelial cells; this interaction, together with CEACAM5–CD8α binding (requiring the N domain and its glycosylation), activates CD8-associated Lck and enables CD1d-mediated activation of CD8+ suppressor T cells.","method":"Co-immunoprecipitation; domain deletion mutants; N-domain deglycosylation; Lck activation assay; CD8+ T cell suppression assay","journal":"Mucosal immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-specific Co-IP and mutagenesis with functional signaling readout, single laboratory","pmids":["24104458"],"is_preprint":false},{"year":2016,"finding":"Atypical NKT TCRs (TRAV21-TRAJ8-TRBV7-8 and TRAV12-3-TRAJ27-TRBV6-5) dock orthogonally over the A'-pocket of CD1d in a mode distinct from all type I NKT TCR–CD1d complexes, showing that diverse NKT TCR repertoire usage manifests in varied docking strategies and antigen specificities toward CD1d–α-GalCer.","method":"X-ray crystallography of atypical NKT TCR–CD1d–α-GalCer complexes; functional antigen reactivity assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures of multiple ternary complexes with functional validation","pmids":["26875526"],"is_preprint":false},{"year":2019,"finding":"Type II NKT TCR directed against the microbial antigen α-glucuronosyl-diacylglycerol (α-GlcADAG) adopts an F'-pocket docking mode on CD1d, contrasting sharply with the A'-roof positioning of sulfatide-reactive type II NKT TCRs, demonstrating that diverse type II NKT TCRs use multiple distinct recognition strategies on CD1d.","method":"X-ray crystallography of type II NKT TCR–CD1d–α-GlcADAG complex; functional antigen reactivity assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure of ternary complex with functional validation, mechanistically distinct from prior structures","pmids":["31748533"],"is_preprint":false},{"year":2017,"finding":"A TCR trap method capturing lipid antigens at the CD1d–TCR interface identified α-linked monohexosylceramides from cow's milk as endogenous iNKT cell antigens, directly biochemically proving α-anomeric lipid antigens from a common dietary source occupy the CD1d–TCR interface.","method":"CD1d-lipid-TCR complex capture (TCR trap); mass spectrometry fragmentation distinguishing α- from β-anomeric monohexosylceramides","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — novel direct biochemical antigen capture method with MS identification, single laboratory","pmids":["28716901"],"is_preprint":false},{"year":2018,"finding":"CD1d-lipid presentation by regulatory B cells (Bregs) drives iNKT cells to secrete IFN-γ, which contributes to downregulation of Th1 and Th17 responses and amelioration of experimental arthritis; mice lacking CD1d-expressing B cells fail to respond to α-GalCer treatment, and loss of B cell CD1d alters iNKT cell metabolic and cytokine regulation.","method":"Chimeric mice; B cell depletion and adoptive cell transfer; CD1d-conditional B cell-specific knockout; experimental arthritis model; cytokine and metabolic assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genetic/cell transfer approaches with functional immune and disease readouts, single laboratory","pmids":["29449556"],"is_preprint":false},{"year":2024,"finding":"Amine headgroups of ionizable lipids in lipid nanoparticles directly bind to CD1d (and TLR4) and promote lipid-raft formation, driving LNP immunogenicity; these inflammatory signals inhibit anti-PEG IgM production, preventing loss of LNP efficacy on repeated dosing.","method":"Direct binding assays (CD1d and TLR4); lipid raft formation assays; immunoglobulin isotype profiling; cytokine measurement; structure-activity analysis of ionizable lipid headgroups","journal":"Nature biomedical engineering","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding demonstrated plus functional immune readouts, single laboratory","pmids":["39363106"],"is_preprint":false}],"current_model":"CD1d is a non-polymorphic MHC class I-like molecule that presents lipid and glycolipid antigens (loaded in the ER by MTP and in endosomes by saposins) to NKT cells via a conserved parallel/orthogonal TCR docking mode; its cytoplasmic tail mediates ubiquitin-dependent endocytosis (exploited by pathogens), JAK2-STAT3 anti-apoptotic signaling in hepatocytes, and Pyk2-dependent serotonin secretion in enterochromaffin cells, while its surface expression is regulated transcriptionally by PPARγ/RARα/retinoic acid, IFN-γ, miR-155/Ets-1, and HDAC2, and post-translationally by ER stress and β2-microglobulin-dependent glycan maturation."},"narrative":{"mechanistic_narrative":"CD1d is a non-polymorphic MHC class I-like antigen-presenting molecule that loads lipid and glycolipid antigens and displays them at the cell surface to NKT cells, governing innate-like T cell immunity at barrier and lymphoid sites [PMID:17581592, PMID:10523605]. Maturation and trafficking of CD1d depend on β2-microglobulin, which is required for Golgi transit and acquisition of endoglycosidase-H-resistant mature glycosylation [PMID:10092605]. Antigen loading is orchestrated in the ER by microsomal triglyceride transfer protein (MTP), which associates with CD1d and directly transfers phospholipids onto nascent molecules, a step required for presentation of both exogenous α-galactosylceramide and endogenous lipids [PMID:15107843, PMID:16087713]. The CD1d groove accommodates a broad spectrum of lipids — glycosphingolipids, phosphatidylinositol, cardiolipin, lysophosphatidylcholine, sphingomyelin, and dietary α-linked monohexosylceramides — with the presented species and its conformation dictating recognition outcomes [PMID:10523605, PMID:21376640, PMID:21389252, PMID:22395072, PMID:31636468, PMID:28716901]. Structural studies establish that type I (invariant) NKT TCRs dock parallel at the extreme end of the cleft via conserved germline-encoded α-chain contacts, while autoreactivity is conferred by a hydrophobic CDR3β motif; γδ and atypical/type II NKT TCRs instead engage CD1d orthogonally over the A' or F' pockets, defining a repertoire of distinct docking strategies [PMID:17581592, PMID:24076636, PMID:21376640, PMID:26875526, PMID:31748533]. Beyond antigen display, the CD1d cytoplasmic tail transduces intrinsic signals: tail tyrosine phosphorylation recruits JAK2 to activate STAT3 and anti-apoptotic effectors protecting hepatocytes, epithelial CD1d engagement drives a protective STAT3→IL-10 axis whose loss causes NKT-mediated colitis, and in enterochromaffin cells CD1d ligation activates Pyk2 to trigger serotonin secretion [PMID:24717441, PMID:38438948, PMID:37354904]. CD1d surface levels are controlled transcriptionally and post-transcriptionally by retinoic acid/RARα and PPARγ, IFN-γ, miR-155/Ets-1, and HDAC2, and post-translationally by ER stress and ubiquitin-dependent endocytosis, the latter exploited by KSHV MIR proteins and HIV-1 Nef to evade NKT surveillance [PMID:15864354, PMID:15916790, PMID:16982809, PMID:8760056, PMID:24717441, PMID:25929465, PMID:27614429].","teleology":[{"year":1996,"claim":"Established that CD1d expression is inducible, showing IFN-γ drives CD1d mRNA and surface protein on intestinal epithelium and linking the molecule to inflammatory regulation.","evidence":"Whole-cell ELISA and RT-PCR across epithelial cell lines with cytokine specificity controls","pmids":["8760056"],"confidence":"Medium","gaps":["Did not identify the transcription factors mediating induction","No NKT functional readout linked to the increased expression"]},{"year":1999,"claim":"Defined the biosynthetic and localization requirements of CD1d, showing β2m association is required for Golgi transit and mature glycosylation while β2m-independent immature forms reach the surface, particularly apically in epithelium.","evidence":"Pulse-chase metabolic labeling, endo-H/N-glycanase digestion, surface biotinylation, and confocal microscopy in transfected and epithelial cells","pmids":["10092605","10221650"],"confidence":"High","gaps":["Functional consequence of the β2m-independent apical form for antigen presentation unresolved","Did not address lipid loading along this trafficking route"]},{"year":1999,"claim":"Provided the first quantitative biophysical proof that CD1d directly binds glycolipid antigen, establishing it as a lipid-binding presentation molecule with broad ligand capacity.","evidence":"Surface plasmon resonance and plate-bound presentation assays with purified recombinant soluble CD1d","pmids":["10523605"],"confidence":"High","gaps":["Did not resolve the structural basis of TCR engagement","Loading mechanism in cells not addressed"]},{"year":2001,"claim":"Enabled direct detection of antigen-specific NKT cells by reconstituting functional CD1d-glycolipid tetramers, providing a tool that anchored subsequent functional and clinical studies.","evidence":"Oxidative refolding chromatography of denatured CD1d/β2m with synthetic lipids and ex vivo tetramer staining","pmids":["11248072"],"confidence":"Medium","gaps":["Methodological advance rather than mechanistic insight into CD1d biology","Single laboratory"]},{"year":2005,"claim":"Identified the ER chaperone that loads CD1d, showing MTP associates with CD1d and directly transfers phospholipids onto it, a step required in vivo for NKT activation.","evidence":"Reciprocal Co-IP, hepatocyte-specific Mttp knockout, siRNA, and in vitro lipid transfer with purified MTP and recombinant CD1d","pmids":["15107843","16087713"],"confidence":"High","gaps":["How MTP-loaded endogenous lipids are exchanged for antigenic lipids in endosomes not defined","Selectivity for phospholipids over other ER lipids incompletely mapped"]},{"year":2005,"claim":"Revealed the CD1d cytoplasmic tail as a target of pathogen immune evasion, with KSHV MIR proteins ubiquitinating a tail lysine to trigger endocytosis and HIV-1 Nef binding the tail to downregulate surface CD1d.","evidence":"Ubiquitination and endocytosis assays, Co-IP, and cytoplasmic tail mutant/deletion constructs with NKT activation readouts","pmids":["15864354","15916790"],"confidence":"Medium","gaps":["Nef interaction shown in a single laboratory without reciprocal validation in infection","Endogenous host machinery that normally uses this endocytosis signal not fully identified"]},{"year":2006,"claim":"Established retinoic acid signaling as a direct transcriptional control of CD1d, with PPARγ acting upstream through ATRA synthesis and RARα directly driving CD1d expression in dendritic cells and B cells.","evidence":"Pharmacological PPARγ/RARα modulation, enzyme assays, and iNKT co-culture in human DCs and B cells","pmids":["16982809","21451111"],"confidence":"Medium","gaps":["Direct RARα occupancy of the CD1D promoter not shown structurally","Single laboratory for each cell type"]},{"year":2007,"claim":"Resolved the molecular docking mode of the canonical NKT TCR, showing parallel binding at the cleft end with conserved germline α-chain contacts to the CD1d-antigen complex.","evidence":"X-ray crystallography of the NKT TCR–CD1d–α-GalCer ternary complex","pmids":["17581592"],"confidence":"High","gaps":["Did not explain recognition of self versus foreign lipids","Limited to a single TCR/antigen pair"]},{"year":2007,"claim":"Linked organelle stress to CD1d function, showing ER stress in steatotic hepatocytes impairs CD1d trafficking and depletes liver NKT cells despite normal mRNA.","evidence":"Subcellular fractionation, surface flow cytometry, and T cell activation in ob/ob and tunicamycin-treated mice","pmids":["17607300"],"confidence":"Medium","gaps":["Molecular checkpoint coupling the UPR to CD1d export not identified","Single laboratory"]},{"year":2011,"claim":"Explained the structural basis of NKT autoreactivity and broadened the lipidome CD1d can present, showing a CDR3β hydrophobic motif drives self-recognition and that cardiolipin loading stimulates γδ T cells.","evidence":"High-resolution crystal structures of NKT TCR–PI–CD1d and CD1d–cardiolipin complexes with functional T cell assays","pmids":["21376640","21389252"],"confidence":"High","gaps":["Physiological abundance of these self-lipids on CD1d not quantified","γδ recognition of cardiolipin structurally inferred rather than co-crystallized"]},{"year":2012,"claim":"Demonstrated antigen-induced conformational plasticity of CD1d, with lysophosphatidylcholine opening the A' pocket and TCR binding enforcing headgroup displacement and a closed conformation.","evidence":"Crystal structures of CD1d–LPC and the iNKT TCR ternary complex with functional iNKT assays","pmids":["22395072"],"confidence":"High","gaps":["Generality of induced-fit recognition across other lysolipids not established","Single antigen-TCR pair"]},{"year":2013,"claim":"Expanded the CD1d-restricted TCR universe, showing a Vδ1 γδ TCR docks orthogonally over the A' pocket using germline CDR1δ, distinct from invariant NKT recognition.","evidence":"X-ray crystallography of a γδ TCR–CD1d–α-GalCer complex with primary γδ T cell functional assays","pmids":["24076636"],"confidence":"High","gaps":["In vivo antigens driving γδ recognition of CD1d not defined","Single TCR studied"]},{"year":2013,"claim":"Identified a co-receptor partnership for epithelial CD1d, showing CEACAM5 binds CD1d via its B3 domain and bridges CD8α to activate Lck and CD8+ suppressor T cells.","evidence":"Domain-mapped Co-IP, deglycosylation mutants, and Lck activation/suppression assays in intestinal epithelium","pmids":["24104458"],"confidence":"Medium","gaps":["Single laboratory without reciprocal in vivo validation","Lipid antigen requirement for this CD8+ T cell activation unclear"]},{"year":2014,"claim":"Established intrinsic epithelial CD1d signaling as protective, defining a CD1d→STAT3→IL-10/HSP110 axis whose loss causes NKT-mediated colitis.","evidence":"IEC-specific conditional deletion of CD1d, MTP, IL-10, and HSP110 with STAT3 assays, colitis models, and bone marrow chimeras","pmids":["24717441"],"confidence":"High","gaps":["Upstream ligand triggering epithelial CD1d signaling in vivo not defined","Connection to the tail tyrosine signaling described later not yet integrated"]},{"year":2015,"claim":"Defined post-transcriptional and transcriptional repression of CD1d on B cells, with TLR9-induced miR-155 targeting the CD1D 3'-UTR and Ets-1 directly regulating transcription, with relevance to SLE.","evidence":"3'-UTR luciferase reporters, miR-155 gain/loss, Ets-1 binding analysis, and iNKT activation assays","pmids":["25929465"],"confidence":"Medium","gaps":["Relative contributions of miR-155 versus Ets-1 in vivo not quantified","Single laboratory"]},{"year":2016,"claim":"Identified chromatin-level control of CD1d, showing HDAC2 occupies the CD1D promoter and represses expression, with HDAC inhibition enhancing NKT responses against lymphoma.","evidence":"ChIP at the CD1D promoter, HDAC2 siRNA, and NKT activation/HDAC inhibitor assays","pmids":["27614429"],"confidence":"Medium","gaps":["Histone marks and co-repressors at the locus not mapped","Single laboratory"]},{"year":2016,"claim":"Showed that diverse NKT TCR repertoire usage manifests as varied docking geometries, with atypical NKT TCRs engaging CD1d orthogonally over the A' pocket.","evidence":"Crystal structures of multiple atypical NKT TCR–CD1d–α-GalCer complexes with antigen reactivity assays","pmids":["26875526"],"confidence":"High","gaps":["Functional significance of docking diversity for in vivo selection not resolved","Limited number of TCRs sampled"]},{"year":2017,"claim":"Linked hepatocyte CD1d to liver iNKT homeostasis, showing hepatocyte-specific loss of MTP or CD1d increases liver iNKT numbers through altered iNKT apoptosis, and biochemically captured a dietary α-anomeric antigen at the CD1d–TCR interface.","evidence":"Conditional hepatocyte MTP/CD1d knockouts with apoptosis/hepatitis models, and TCR-trap capture with mass spectrometry of milk monohexosylceramides","pmids":["28893990","28716901"],"confidence":"High","gaps":["Mechanism by which hepatocyte CD1d controls iNKT apoptosis not molecularly defined","Antigen capture from a single laboratory"]},{"year":2018,"claim":"Demonstrated a regulatory immune function for B cell CD1d, showing Breg CD1d-lipid presentation drives iNKT IFN-γ to dampen Th1/Th17 responses and ameliorate arthritis.","evidence":"B cell-conditional CD1d knockout, chimeras, adoptive transfer, and experimental arthritis with cytokine/metabolic assays","pmids":["29449556"],"confidence":"Medium","gaps":["Endogenous lipid antigen presented by Bregs not identified","Single laboratory"]},{"year":2019,"claim":"Identified sphingomyelin as a non-activating CD1d ligand whose accumulation impairs antigen presentation, linking acid sphingomyelinase to thymic iNKT selection, and structurally diversified type II NKT recognition via an F'-pocket docking mode.","evidence":"ASM-deficient mouse/human (Niemann-Pick) studies with pharmacological rescue, plus crystallography of a type II NKT TCR–CD1d–α-GlcADAG complex","pmids":["31636468","31748533"],"confidence":"High","gaps":["How sphingomyelin is normally turned over to permit antigen loading in vivo incompletely defined","Breadth of type II recognition modes not exhausted"]},{"year":2022,"claim":"Uncovered a metabolic regulatory role for CD1d in macrophages, controlling CD36 internalization to limit lipid import and restrain TLR-driven cytokine secretion.","evidence":"CD1d-KO macrophage transcriptomics/metabolomics, CD36 internalization assays, and pharmacological CD36 blockade rescue","pmids":["36344546"],"confidence":"Medium","gaps":["Molecular link between CD1d and CD36 trafficking not defined","Single laboratory"]},{"year":2023,"claim":"Defined intrinsic CD1d tail signaling pathways, showing tail tyrosine phosphorylation recruits JAK2 to activate STAT3 anti-apoptotic signaling in hepatocytes, and CD1d ligation activates Pyk2 to drive serotonin secretion from enterochromaffin cells.","evidence":"Hepatocyte CD1d gain/loss with crosslinking and JAK2/STAT3 assays in lipotoxicity/liver injury models; iNKT–EC co-culture with Pyk2 inhibition, calcium imaging, and germ-free mice","pmids":["38438948","37354904"],"confidence":"Medium","gaps":["Physiological ligand triggering hepatocyte CD1d phosphorylation not identified","Both mechanisms from single laboratories"]},{"year":2024,"claim":"Extended CD1d ligand recognition to synthetic lipids, showing ionizable lipid amine headgroups in nanoparticles bind CD1d and promote lipid-raft-driven immunogenicity that suppresses anti-PEG IgM.","evidence":"Direct binding assays, lipid raft and cytokine measurements, and structure-activity analysis of ionizable lipid headgroups","pmids":["39363106"],"confidence":"Medium","gaps":["Structural mode of ionizable lipid binding to CD1d not resolved","Single laboratory"]},{"year":null,"claim":"How the distinct CD1d cytoplasmic-tail signaling modules (ubiquitin-dependent endocytosis, JAK2-STAT3, Pyk2) are integrated, what physiological ligands trigger them, and how lipid loading is coordinated across ER and endosomal compartments remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking tail tyrosine phosphorylation events to downstream effectors across cell types","Endogenous physiological triggers of CD1d intrinsic signaling unknown","In vivo lipid exchange machinery downstream of MTP not fully mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[3,4,5,6,7,22,31,33]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[16,19,27,20]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[16,19]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,9,11,12,17]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,3,17]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[11]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,2,16,32]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[16,19,27]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[18,19,20]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[26]}],"complexes":[],"partners":["B2M","MTTP","JAK2","CEACAM5","NEF","MIR2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P15813","full_name":"Antigen-presenting glycoprotein CD1d","aliases":["R3G1"],"length_aa":335,"mass_kda":37.7,"function":"Antigen-presenting protein that binds self and non-self glycolipids and presents them to T-cell receptors on natural killer T-cells","subcellular_location":"Cell membrane; Basolateral cell membrane; Endosome membrane; Lysosome membrane; Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/P15813/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD1D","classification":"Not Classified","n_dependent_lines":21,"n_total_lines":1208,"dependency_fraction":0.0173841059602649},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD1D","total_profiled":1310},"omim":[{"mim_id":"619850","title":"ALPHA-1,3-GALACTOSYLTRANSFERASE 2; A3GALT2","url":"https://www.omim.org/entry/619850"},{"mim_id":"611817","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY K, MEMBER 1; KLRK1","url":"https://www.omim.org/entry/611817"},{"mim_id":"610703","title":"HEAT-SHOCK 105/110-KD PROTEIN 1; HSPH1","url":"https://www.omim.org/entry/610703"},{"mim_id":"606963","title":"PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD","url":"https://www.omim.org/entry/606963"},{"mim_id":"604274","title":"KILLER CELL LECTIN-LIKE RECEPTOR A1, PSEUDOGENE; KLRA1P","url":"https://www.omim.org/entry/604274"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Endoplasmic reticulum","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":9.6},{"tissue":"liver","ntpm":8.5},{"tissue":"lymphoid tissue","ntpm":13.2}],"url":"https://www.proteinatlas.org/search/CD1D"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P15813","domains":[{"cath_id":"3.30.500.10","chopping":"26-201","consensus_level":"high","plddt":96.0037,"start":26,"end":201},{"cath_id":"2.60.40.10","chopping":"207-295","consensus_level":"high","plddt":96.5008,"start":207,"end":295}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P15813","model_url":"https://alphafold.ebi.ac.uk/files/AF-P15813-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P15813-F1-predicted_aligned_error_v6.png","plddt_mean":89.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD1D","jax_strain_url":"https://www.jax.org/strain/search?query=CD1D"},"sequence":{"accession":"P15813","fasta_url":"https://rest.uniprot.org/uniprotkb/P15813.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P15813/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P15813"}},"corpus_meta":[{"pmid":"17581592","id":"PMC_17581592","title":"CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17581592","citation_count":482,"is_preprint":false},{"pmid":"23154222","id":"PMC_23154222","title":"Recognition of CD1d-restricted antigens by natural killer T cells.","date":"2012","source":"Nature reviews. Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23154222","citation_count":370,"is_preprint":false},{"pmid":"18501573","id":"PMC_18501573","title":"CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.","date":"2008","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18501573","citation_count":341,"is_preprint":false},{"pmid":"24076636","id":"PMC_24076636","title":"CD1d-lipid antigen recognition by the γδ TCR.","date":"2013","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24076636","citation_count":271,"is_preprint":false},{"pmid":"10352254","id":"PMC_10352254","title":"Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10352254","citation_count":239,"is_preprint":false},{"pmid":"12928408","id":"PMC_12928408","title":"CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12928408","citation_count":184,"is_preprint":false},{"pmid":"24717441","id":"PMC_24717441","title":"Protective mucosal immunity mediated by epithelial CD1d and IL-10.","date":"2014","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/24717441","citation_count":174,"is_preprint":false},{"pmid":"16982809","id":"PMC_16982809","title":"PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells.","date":"2006","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16982809","citation_count":157,"is_preprint":false},{"pmid":"10809957","id":"PMC_10809957","title":"CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes.","date":"2000","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10809957","citation_count":156,"is_preprint":false},{"pmid":"11034419","id":"PMC_11034419","title":"Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11034419","citation_count":156,"is_preprint":false},{"pmid":"30300581","id":"PMC_30300581","title":"Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting.","date":"2018","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/30300581","citation_count":156,"is_preprint":false},{"pmid":"15864354","id":"PMC_15864354","title":"Regulation of CD1d expression and function by a herpesvirus infection.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15864354","citation_count":147,"is_preprint":false},{"pmid":"11248072","id":"PMC_11248072","title":"Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11248072","citation_count":142,"is_preprint":false},{"pmid":"15107843","id":"PMC_15107843","title":"CD1d function is regulated by microsomal triglyceride transfer protein.","date":"2004","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15107843","citation_count":137,"is_preprint":false},{"pmid":"12368486","id":"PMC_12368486","title":"CD1d and invariant NKT cells at the human maternal-fetal interface.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12368486","citation_count":134,"is_preprint":false},{"pmid":"11304550","id":"PMC_11304550","title":"The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families.","date":"2001","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11304550","citation_count":131,"is_preprint":false},{"pmid":"16087713","id":"PMC_16087713","title":"Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16087713","citation_count":127,"is_preprint":false},{"pmid":"12764370","id":"PMC_12764370","title":"Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.","date":"2003","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/12764370","citation_count":126,"is_preprint":false},{"pmid":"10523605","id":"PMC_10523605","title":"Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules.","date":"1999","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10523605","citation_count":125,"is_preprint":false},{"pmid":"21376640","id":"PMC_21376640","title":"A molecular basis for NKT cell recognition of CD1d-self-antigen.","date":"2011","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/21376640","citation_count":116,"is_preprint":false},{"pmid":"7688787","id":"PMC_7688787","title":"CD1d is involved in T cell-intestinal epithelial cell interactions.","date":"1993","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/7688787","citation_count":114,"is_preprint":false},{"pmid":"16870416","id":"PMC_16870416","title":"CD1d- and MR1-restricted invariant T cells: of mice and men.","date":"2006","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16870416","citation_count":110,"is_preprint":false},{"pmid":"21389252","id":"PMC_21389252","title":"Cardiolipin binds to CD1d and stimulates CD1d-restricted γδ T cells in the normal murine repertoire.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21389252","citation_count":108,"is_preprint":false},{"pmid":"16083968","id":"PMC_16083968","title":"The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy.","date":"2005","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/16083968","citation_count":107,"is_preprint":false},{"pmid":"19945296","id":"PMC_19945296","title":"Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.","date":"2009","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19945296","citation_count":101,"is_preprint":false},{"pmid":"21095162","id":"PMC_21095162","title":"Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans.","date":"2010","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/21095162","citation_count":96,"is_preprint":false},{"pmid":"18566372","id":"PMC_18566372","title":"Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18566372","citation_count":95,"is_preprint":false},{"pmid":"19056691","id":"PMC_19056691","title":"Regulation of multiple myeloma survival and progression by CD1d.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19056691","citation_count":92,"is_preprint":false},{"pmid":"19945889","id":"PMC_19945889","title":"Antigen recognition by CD1d-restricted NKT T cell receptors.","date":"2009","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19945889","citation_count":89,"is_preprint":false},{"pmid":"15207777","id":"PMC_15207777","title":"The immunoregulatory role of CD1d-restricted natural killer T cells in disease.","date":"2004","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/15207777","citation_count":89,"is_preprint":false},{"pmid":"16148122","id":"PMC_16148122","title":"The influence of CD1d in postselection NKT cell maturation and homeostasis.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16148122","citation_count":88,"is_preprint":false},{"pmid":"15342907","id":"PMC_15342907","title":"CD1d-restricted T cell activation by nonlipidic small molecules.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15342907","citation_count":85,"is_preprint":false},{"pmid":"16517731","id":"PMC_16517731","title":"Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16517731","citation_count":84,"is_preprint":false},{"pmid":"17607300","id":"PMC_17607300","title":"Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers.","date":"2007","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17607300","citation_count":79,"is_preprint":false},{"pmid":"15128771","id":"PMC_15128771","title":"Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15128771","citation_count":77,"is_preprint":false},{"pmid":"16520393","id":"PMC_16520393","title":"Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.","date":"2006","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16520393","citation_count":76,"is_preprint":false},{"pmid":"10092605","id":"PMC_10092605","title":"Biochemical characterization of CD1d expression in the absence of beta2-microglobulin.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10092605","citation_count":76,"is_preprint":false},{"pmid":"9731549","id":"PMC_9731549","title":"Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis.","date":"1998","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9731549","citation_count":75,"is_preprint":false},{"pmid":"39363106","id":"PMC_39363106","title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d.","date":"2024","source":"Nature biomedical engineering","url":"https://pubmed.ncbi.nlm.nih.gov/39363106","citation_count":74,"is_preprint":false},{"pmid":"29449556","id":"PMC_29449556","title":"CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29449556","citation_count":74,"is_preprint":false},{"pmid":"18077787","id":"PMC_18077787","title":"Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18077787","citation_count":73,"is_preprint":false},{"pmid":"16794785","id":"PMC_16794785","title":"Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands.","date":"2006","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/16794785","citation_count":72,"is_preprint":false},{"pmid":"30635655","id":"PMC_30635655","title":"BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30635655","citation_count":69,"is_preprint":false},{"pmid":"15916790","id":"PMC_15916790","title":"Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex.","date":"2005","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/15916790","citation_count":69,"is_preprint":false},{"pmid":"8760056","id":"PMC_8760056","title":"IFN-gamma modulates CD1d surface expression on intestinal epithelia.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8760056","citation_count":62,"is_preprint":false},{"pmid":"10221650","id":"PMC_10221650","title":"Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form.","date":"1999","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10221650","citation_count":60,"is_preprint":false},{"pmid":"15477656","id":"PMC_15477656","title":"Regulation of immune responses by CD1d-restricted natural killer T cells.","date":"2004","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/15477656","citation_count":58,"is_preprint":false},{"pmid":"27405300","id":"PMC_27405300","title":"Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.","date":"2016","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/27405300","citation_count":57,"is_preprint":false},{"pmid":"21451111","id":"PMC_21451111","title":"CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21451111","citation_count":56,"is_preprint":false},{"pmid":"22395072","id":"PMC_22395072","title":"Lysophospholipid presentation by CD1d and recognition by a human Natural Killer T-cell receptor.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22395072","citation_count":56,"is_preprint":false},{"pmid":"27329323","id":"PMC_27329323","title":"Adipocyte-specific CD1d-deficiency mitigates diet-induced obesity and insulin resistance in mice.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27329323","citation_count":54,"is_preprint":false},{"pmid":"29378774","id":"PMC_29378774","title":"CD1d-mediated lipid presentation by CD11c+ cells regulates intestinal homeostasis.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/29378774","citation_count":53,"is_preprint":false},{"pmid":"33451981","id":"PMC_33451981","title":"A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia.","date":"2021","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/33451981","citation_count":50,"is_preprint":false},{"pmid":"31636468","id":"PMC_31636468","title":"Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31636468","citation_count":48,"is_preprint":false},{"pmid":"11145861","id":"PMC_11145861","title":"Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions.","date":"2000","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11145861","citation_count":43,"is_preprint":false},{"pmid":"22041925","id":"PMC_22041925","title":"CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.","date":"2011","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22041925","citation_count":43,"is_preprint":false},{"pmid":"28716901","id":"PMC_28716901","title":"Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28716901","citation_count":43,"is_preprint":false},{"pmid":"25381357","id":"PMC_25381357","title":"Role and regulation of CD1d in normal and pathological B cells.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25381357","citation_count":42,"is_preprint":false},{"pmid":"38438948","id":"PMC_38438948","title":"CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis.","date":"2023","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/38438948","citation_count":41,"is_preprint":false},{"pmid":"26875526","id":"PMC_26875526","title":"Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26875526","citation_count":40,"is_preprint":false},{"pmid":"15030309","id":"PMC_15030309","title":"CD1d-mediated antigen presentation to natural killer T (NKT) cells.","date":"2003","source":"Critical reviews in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15030309","citation_count":40,"is_preprint":false},{"pmid":"14711586","id":"PMC_14711586","title":"Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells.","date":"2004","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/14711586","citation_count":40,"is_preprint":false},{"pmid":"27799287","id":"PMC_27799287","title":"CD1d-mediated activation of group 3 innate lymphoid cells drives IL-22 production.","date":"2016","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/27799287","citation_count":40,"is_preprint":false},{"pmid":"15810882","id":"PMC_15810882","title":"CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity.","date":"2005","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15810882","citation_count":39,"is_preprint":false},{"pmid":"18253929","id":"PMC_18253929","title":"Viral danger signals control CD1d de novo synthesis and NKT cell activation.","date":"2008","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18253929","citation_count":39,"is_preprint":false},{"pmid":"16424169","id":"PMC_16424169","title":"A cell-type specific CD1d expression program modulates invariant NKT cell development and function.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16424169","citation_count":37,"is_preprint":false},{"pmid":"36344546","id":"PMC_36344546","title":"CD1d-dependent rewiring of lipid metabolism in macrophages regulates innate immune responses.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36344546","citation_count":37,"is_preprint":false},{"pmid":"12787763","id":"PMC_12787763","title":"T-cell effector mechanisms: gammadelta and CD1d-restricted subsets.","date":"2003","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12787763","citation_count":36,"is_preprint":false},{"pmid":"17476670","id":"PMC_17476670","title":"Roles of CD1d-restricted NKT cells in the intestine.","date":"2007","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17476670","citation_count":36,"is_preprint":false},{"pmid":"17015708","id":"PMC_17015708","title":"Expression of CD1d molecules by human schwann cells and potential interactions with immunoregulatory invariant NK T cells.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17015708","citation_count":36,"is_preprint":false},{"pmid":"35122066","id":"PMC_35122066","title":"A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response.","date":"2020","source":"Nature cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35122066","citation_count":35,"is_preprint":false},{"pmid":"26322041","id":"PMC_26322041","title":"CD1d- and MR1-Restricted T Cells in Sepsis.","date":"2015","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26322041","citation_count":32,"is_preprint":false},{"pmid":"25805574","id":"PMC_25805574","title":"CD1d-dependent endogenous and exogenous lipid antigen presentation.","date":"2015","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25805574","citation_count":32,"is_preprint":false},{"pmid":"15548574","id":"PMC_15548574","title":"Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15548574","citation_count":32,"is_preprint":false},{"pmid":"25929465","id":"PMC_25929465","title":"TLR9-induced miR-155 and Ets-1 decrease expression of CD1d on B cells in SLE.","date":"2015","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25929465","citation_count":32,"is_preprint":false},{"pmid":"12952923","id":"PMC_12952923","title":"Intestinal heat shock protein 110 regulates expression of CD1d on intestinal epithelial cells.","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12952923","citation_count":32,"is_preprint":false},{"pmid":"18458073","id":"PMC_18458073","title":"Expression of CD1d and ligand-induced cytokine production are tissue specific in mucosal epithelia of the human lower reproductive tract.","date":"2008","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18458073","citation_count":32,"is_preprint":false},{"pmid":"23065503","id":"PMC_23065503","title":"Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.","date":"2012","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/23065503","citation_count":31,"is_preprint":false},{"pmid":"22734667","id":"PMC_22734667","title":"Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.","date":"2012","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22734667","citation_count":31,"is_preprint":false},{"pmid":"28392574","id":"PMC_28392574","title":"M2-specific reduction of CD1d switches NKT cell-mediated immune responses and triggers metaflammation in adipose tissue.","date":"2017","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28392574","citation_count":31,"is_preprint":false},{"pmid":"27297969","id":"PMC_27297969","title":"Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.","date":"2016","source":"Pathogens and disease","url":"https://pubmed.ncbi.nlm.nih.gov/27297969","citation_count":30,"is_preprint":false},{"pmid":"30210497","id":"PMC_30210497","title":"Role of CD1d- and MR1-Restricted T Cells in Asthma.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30210497","citation_count":29,"is_preprint":false},{"pmid":"28893990","id":"PMC_28893990","title":"CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28893990","citation_count":29,"is_preprint":false},{"pmid":"23797666","id":"PMC_23797666","title":"BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/23797666","citation_count":29,"is_preprint":false},{"pmid":"27614429","id":"PMC_27614429","title":"Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.","date":"2016","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/27614429","citation_count":28,"is_preprint":false},{"pmid":"15790518","id":"PMC_15790518","title":"Human immunodeficiency virus gp120 downregulates CD1d cell surface expression.","date":"2004","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/15790518","citation_count":26,"is_preprint":false},{"pmid":"29599785","id":"PMC_29599785","title":"CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29599785","citation_count":25,"is_preprint":false},{"pmid":"37354904","id":"PMC_37354904","title":"Lipids regulate peripheral serotonin release via gut CD1d.","date":"2023","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/37354904","citation_count":24,"is_preprint":false},{"pmid":"33128583","id":"PMC_33128583","title":"CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy.","date":"2020","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/33128583","citation_count":24,"is_preprint":false},{"pmid":"25930071","id":"PMC_25930071","title":"Targeted disruption of CD1d prevents NKT cell development in pigs.","date":"2015","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/25930071","citation_count":24,"is_preprint":false},{"pmid":"24104458","id":"PMC_24104458","title":"Characterizing CEACAM5 interaction with CD8α and CD1d in intestinal homeostasis.","date":"2013","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24104458","citation_count":24,"is_preprint":false},{"pmid":"15925541","id":"PMC_15925541","title":"Development and function of CD1d-restricted NKT cells: influence of sphingolipids, SAP and sex.","date":"2005","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15925541","citation_count":23,"is_preprint":false},{"pmid":"11995808","id":"PMC_11995808","title":"Ocular immune privilege and CD1d-reactive natural killer T cells.","date":"2002","source":"Cornea","url":"https://pubmed.ncbi.nlm.nih.gov/11995808","citation_count":23,"is_preprint":false},{"pmid":"29509047","id":"PMC_29509047","title":"Adipocyte CD1d determines adipose inflammation and insulin resistance in obesity.","date":"2018","source":"Adipocyte","url":"https://pubmed.ncbi.nlm.nih.gov/29509047","citation_count":22,"is_preprint":false},{"pmid":"19265113","id":"PMC_19265113","title":"CD1d activation and blockade: a new antitumor strategy.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19265113","citation_count":22,"is_preprint":false},{"pmid":"31748533","id":"PMC_31748533","title":"Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31748533","citation_count":22,"is_preprint":false},{"pmid":"21050191","id":"PMC_21050191","title":"γδ T lymphocytes kill T regulatory cells through CD1d.","date":"2010","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21050191","citation_count":22,"is_preprint":false},{"pmid":"27069116","id":"PMC_27069116","title":"CD1d-restricted peripheral T cell lymphoma in mice and humans.","date":"2016","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27069116","citation_count":21,"is_preprint":false},{"pmid":"28633979","id":"PMC_28633979","title":"Zerumbone modulates CD1d expression and lipid antigen presentation pathway in breast cancer cells.","date":"2017","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/28633979","citation_count":21,"is_preprint":false},{"pmid":"23774666","id":"PMC_23774666","title":"The CD1d-natural killer T cell axis in atherosclerosis.","date":"2013","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23774666","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43926,"output_tokens":8188,"usd":0.127299,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18183,"output_tokens":7067,"usd":0.133795,"stage2_stop_reason":"end_turn"},"total_usd":0.261094,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of human NKT TCR complexed with CD1d bound to α-galactosylceramide revealed that the NKT TCR docks parallel to, and at the extreme end of, the CD1d-binding cleft in a lock-and-key interaction with the lipid antigen, with the conserved TCR α-chain making primary contacts with the CD1d-antigen complex.\",\n      \"method\": \"X-ray crystallography of NKT TCR–CD1d–α-GalCer ternary complex\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with direct molecular detail of docking mode, published in high-impact peer-reviewed journal\",\n      \"pmids\": [\"17581592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A human Vδ1+ γδ TCR binds CD1d–α-GalCer orthogonally over the A' pocket of CD1d, with the Vδ1-chain and germline-encoded CDR1δ loop dominating CD1d contacts, while the CDR3γ loop determines α-GalCer specificity—a docking mode distinct from type I NKT TCRs.\",\n      \"method\": \"X-ray crystallography of γδ TCR–CD1d–α-GalCer complex; functional assays with primary γδ T cells\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus functional validation, distinct docking mode established rigorously\",\n      \"pmids\": [\"24076636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Microsomal triglyceride transfer protein (MTP), residing in the endoplasmic reticulum, associates with CD1d in hepatocytes and is required for CD1d-mediated glycolipid antigen presentation; conditional deletion of Mttp in hepatocytes redistributes CD1d expression and abolishes invariant NKT cell activation.\",\n      \"method\": \"Co-immunoprecipitation, conditional hepatocyte-specific Mttp knockout mice, siRNA silencing in intestinal epithelial cells, in vivo NKT activation assays\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, multiple genetic models (conditional KO, siRNA), functional readout replicated across cell types and labs\",\n      \"pmids\": [\"15107843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MTP directly transfers phospholipids (but not triglycerides) onto recombinant CD1d in vitro, functioning as an ER chaperone that loads endogenous lipids onto nascent CD1d; chemical inhibition of MTP lipid transfer reduces CD1d-mediated presentation of α-GalCer and endogenous antigens in dendritic cells.\",\n      \"method\": \"In vitro lipid transfer assay with purified MTP and recombinant CD1d; pharmacological MTP inhibition; siRNA knockdown; MHC class II presentation control\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro reconstitution assay plus orthogonal genetic/pharmacological approaches, replicating findings from PMID:15107843\",\n      \"pmids\": [\"16087713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Soluble mouse and human CD1d molecules bind α-galactosylceramide at neutral pH as measured by surface plasmon resonance; CD1d can also bind non-antigenic β-GalCer and phosphatidylethanolamine, indicating broad lipid-binding capacity. The orientation of the galactose head group is more critical for TCR contact than for CD1d binding.\",\n      \"method\": \"Surface plasmon resonance binding assay, in vitro antigen presentation with plate-bound soluble CD1d, purified recombinant CD1d proteins\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct quantitative binding assay (SPR) with reconstituted soluble molecules, first quantitative analysis of monomeric lipid–CD1d interaction\",\n      \"pmids\": [\"10523605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Crystal structure (2.3 Å) of an autoreactive NKT TCR–phosphatidylinositol–CD1d complex revealed that NKT TCR autoreactivity is mediated by a hydrophobic motif in the non-germline-encoded CDR3β loop that promotes self-association with CD1d, while germline-encoded recognition of CD1d is conserved between self- and foreign antigen recognition.\",\n      \"method\": \"X-ray crystallography; NKT cell functional assays with natural self-antigen-loaded CD1d\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with functional validation, mechanistic basis for autoreactivity defined\",\n      \"pmids\": [\"21376640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CD1d binds cardiolipin (a tetra-acylated phospholipid) with two alkyl chains buried in the binding groove and two exposed to solvent, as revealed by a 2.3 Å crystal structure of murine CD1d–cardiolipin; this complex stimulates splenic and hepatic γδ T cells to proliferate and secrete IFN-γ and RANTES in a CD1d-restricted manner.\",\n      \"method\": \"X-ray crystallography of murine CD1d–cardiolipin complex; lipid loading experiments; in vitro and in vivo γδ T cell stimulation assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus functional in vitro and in vivo validation, orthogonal methods\",\n      \"pmids\": [\"21389252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Human CD1d presenting lysophosphatidylcholine adopts an altered conformation with a shifted α1 helix and open A' pocket compared to glycolipid-loaded CD1d; iNKT TCR binding requires a 7-Å displacement of the LPC headgroup but stabilizes a closed CD1d-LPC conformation, with CDR3α anchoring the TCR footprint.\",\n      \"method\": \"X-ray crystallography of CD1d–LPC and iNKT TCR–CD1d–LPC complexes; functional iNKT cell assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures of both CD1d-lipid and TCR ternary complex with functional validation\",\n      \"pmids\": [\"22395072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"KSHV MIR proteins (MIR1 and MIR2) downregulate CD1d surface expression by ubiquitinating a unique lysine residue in the CD1d α-chain cytoplasmic tail, triggering endocytosis without accelerated lysosomal degradation, resulting in reduced activation of CD1d-restricted T cells.\",\n      \"method\": \"Transfection of MIR proteins into uninfected cells; ubiquitination assays; endocytosis assays; T cell activation assays; cytoplasmic tail mutant CD1d constructs\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct mechanistic dissection using mutagenesis of cytoplasmic tail lysine, endocytosis assays, and functional T cell readout\",\n      \"pmids\": [\"15864354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HIV-1 Nef physically interacts with the cytoplasmic tail of CD1d (requiring the last 6–10 amino acids), reducing CD1d cell surface expression and impairing CD1d-restricted NKT cell activation; tail-deleted CD1d mutants are resistant to Nef-mediated downregulation.\",\n      \"method\": \"Co-immunoprecipitation of Nef and CD1d; flow cytometry of surface CD1d; cytoplasmic tail deletion mutants; NKT cell activation assay\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus mutagenesis and functional assay, single laboratory\",\n      \"pmids\": [\"15916790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PPARγ indirectly upregulates CD1d expression in human dendritic cells by inducing retinol/retinal metabolizing enzymes (RDH10 and RALDH2), increasing intracellular all-trans retinoic acid (ATRA) synthesis; ATRA then activates RARα, which directly drives CD1d transcription and enhanced iNKT cell activation.\",\n      \"method\": \"Gene expression analysis; pharmacological PPARγ activation; enzyme activity assays; RARα pathway dissection; iNKT cell co-culture activation assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multi-step pathway dissected with orthogonal methods in single laboratory, functional readout included\",\n      \"pmids\": [\"16982809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"In the absence of β2-microglobulin (β2m), CD1d is expressed on the cell surface as an endoglycosidase-H-sensitive 45 kDa glycoprotein with immature glycosylation, whereas in the presence of β2m, CD1d acquires endoglycosidase-H resistance (48 kDa mature form); β2m association is required for CD1d to transit through the Golgi and acquire mature glycosylation.\",\n      \"method\": \"Pulse-chase metabolic labeling; endoglycosidase-H and N-glycanase digestion; transfected cell lines with and without β2m; Western blotting\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution with metabolic labeling and glycosylation analysis, rigorous mechanistic dissection\",\n      \"pmids\": [\"10092605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD1d is localized to the apical and lateral surfaces of intestinal epithelial cells, with a large apical intracellular pool; both β2m-associated (48–50 kDa) and non-glycosylated β2m-independent (37 kDa) forms are present, with the 37 kDa form specifically on the apical surface.\",\n      \"method\": \"Confocal laser microscopy; selective apical/basolateral biotin labeling followed by immunoprecipitation; N-glycanase digestion; Western blotting\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by confocal and surface biotinylation with biochemical characterization, single laboratory\",\n      \"pmids\": [\"10221650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"IFN-γ upregulates CD1d mRNA and cell surface protein expression on intestinal epithelial cell lines in a dose- and time-dependent, cytokine-specific manner.\",\n      \"method\": \"Whole-cell ELISA for surface CD1d; RT-PCR for CD1d mRNA; cytokine-specific controls across multiple epithelial cell lines\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct quantitative surface and mRNA assays, cytokine specificity controls, replicated across multiple cell lines\",\n      \"pmids\": [\"8760056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Intestinal lumenal heat shock protein 110 (Hsp110) acts as an autocrine regulator of CD1d surface expression on intestinal epithelial cells, inducing CD1d expression at mRNA and protein levels.\",\n      \"method\": \"RT-PCR; confocal microscopy; cell surface ELISA; Western blot; biochemical fractionation and identification of Hsp110 from lumenal contents; immunolocalization in vivo\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — identification of specific luminal factor plus multiple orthogonal expression assays, single laboratory\",\n      \"pmids\": [\"12952923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"KSHV lytic replication downregulates CD1d surface expression; viral danger signals (type I IFN, TLR ligands, viruses) selectively increase CD1D mRNA and surface CD1d on human myeloid dendritic cells while decreasing CD1A, CD1B, and CD1E, leading to NKT cell activation with a Th1-like response.\",\n      \"method\": \"Flow cytometry of CD1d surface expression; RT-PCR quantification of CD1 family mRNAs; NKT cell co-culture activation assays; type I IFN pathway analysis\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal assays (surface expression, mRNA, NKT activation), single laboratory\",\n      \"pmids\": [\"18253929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Engagement of epithelial CD1d activates STAT3 signaling and drives STAT3-dependent transcription of IL-10, HSP110, and CD1d itself in intestinal epithelial cells; IEC-specific deletion of CD1d (or its regulator MTP) causes severe NKT-cell-mediated colitis, defining a protective epithelial CD1d→STAT3→IL-10 axis.\",\n      \"method\": \"Conditional IEC-specific gene deletion (CD1d, MTP, IL-10, HSP110); STAT3 activation assays; in vivo colitis models; bone marrow chimeras\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple conditional KO models with defined cellular phenotypes, pathway confirmed by epistasis, replicated across components\",\n      \"pmids\": [\"24717441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Endoplasmic reticulum stress in steatotic hepatocytes reduces CD1d protein trafficking to the plasma membrane (despite normal CD1d mRNA levels), impairing CD1d-restricted T cell activation and depleting liver NKT cells; tunicamycin-induced ER stress recapitulates these effects in lean mice.\",\n      \"method\": \"Subcellular fractionation and flow cytometry for surface CD1d; CD1d-restricted T cell activation assays; ob/ob and tunicamycin-treated mouse models\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic link between ER stress and CD1d trafficking, multiple model systems, single laboratory\",\n      \"pmids\": [\"17607300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Hepatocyte-specific loss of MTP causes defective CD1d function and increases liver iNKT cell numbers due to altered iNKT cell apoptosis; hepatocyte-specific CD1d deletion produces the same phenotype, demonstrating that hepatocyte CD1d controls liver iNKT cell homeostasis.\",\n      \"method\": \"Conditional hepatocyte-specific MTP and CD1d knockout mice; flow cytometry; apoptosis assays; iNKT-cell-mediated hepatitis model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent conditional KO models with convergent phenotypes and defined mechanism (altered iNKT apoptosis)\",\n      \"pmids\": [\"28893990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CD1d crosslinking on hepatocytes induces tyrosine phosphorylation of the CD1d cytoplasmic tail, recruiting and activating JAK2, which then phosphorylates STAT3 to upregulate anti-apoptotic effectors (Bcl-xL, Mcl-1) and reduce cleaved caspase 3/7, protecting hepatocytes from apoptosis independently of NKT cell interactions.\",\n      \"method\": \"Hepatocyte-specific CD1d overexpression and knockdown; anti-CD1d crosslinking; JAK2 phosphorylation and STAT3 activation assays; in vitro palmitic acid lipotoxicity model; in vivo liver injury models (HFD, MCD diet, Fas agonist, ConA)\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cytoplasmic tail signaling mechanistically dissected with gain- and loss-of-function plus signaling pathway readouts, single laboratory\",\n      \"pmids\": [\"38438948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Anti-CD1d monoclonal antibody engagement of CD1d on myeloma cells induces caspase-independent cell death associated with Bax overexpression and mitochondrial membrane potential loss; this requires the CD1d cytoplasmic tail but not the tyrosine residue critical for lysosomal sorting.\",\n      \"method\": \"Anti-CD1d mAb crosslinking; apoptosis/cell death assays; cytoplasmic tail deletion/mutation constructs; Bax expression analysis; mitochondrial membrane potential measurement\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of cytoplasmic tail plus multiple cell death assays, single laboratory\",\n      \"pmids\": [\"19056691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CD1d-glycolipid tetramers generated by oxidative refolding chromatography of fully denatured human CD1d and β2m in the presence of synthetic lipids are functional and specific for iNKT cells, enabling ex vivo identification and enumeration of NKT cells in clinical samples.\",\n      \"method\": \"Oxidative refolding chromatography; tetramer construction; ex vivo flow cytometry staining of peripheral blood and intrahepatic T cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of functional CD1d-lipid complexes validated by specific NKT cell staining, methodological paper\",\n      \"pmids\": [\"11248072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Sphingomyelin occupies the CD1d binding groove as a non-activating endogenous lipid; absence of acid sphingomyelinase (ASM) in mice leads to sphingomyelin accumulation, diminished CD1d-restricted antigen presentation, impaired iNKT cell selection in the thymus, and decreased iNKT cell levels; pharmacological ASM administration restores antigen presentation and iNKT cell levels.\",\n      \"method\": \"ASM-deficient mouse and human (Niemann-Pick disease) studies; CD1d antigen presentation assays; thymic iNKT selection analysis; pharmacological ASM administration\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human and mouse genetic models with pharmacological rescue, multiple orthogonal functional readouts\",\n      \"pmids\": [\"31636468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Retinoic acid receptor α (RARα) signaling directly regulates CD1d expression in human B cells; CD40L activation downregulates CD1d by reducing RARα response gene expression, and RARα agonists reverse this downregulation; BCR activation upregulates CD1c independently of RAR signaling.\",\n      \"method\": \"Flow cytometry; RARα agonist treatment; B cell activation with CD40L and BCR crosslinking; functional NKT cell cytotoxicity assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway dissected with pharmacological tools and functional validation, single laboratory\",\n      \"pmids\": [\"21451111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TLR9 activation induces miR-155, which directly targets the 3'-UTR of CD1D mRNA to reduce CD1d expression on B cells; the transcription factor Ets-1 also directly regulates CD1D gene transcription; these mechanisms collectively impair B cell antigen presentation to iNKT cells in SLE.\",\n      \"method\": \"miRNA target site reporter assays (3'-UTR luciferase); miR-155 overexpression/inhibition; Ets-1 transcription factor binding analysis; flow cytometry; iNKT cell activation assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct 3'-UTR targeting validated plus transcriptional regulation, functional readout, single laboratory\",\n      \"pmids\": [\"25929465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HDAC2 binds to the CD1D promoter; knockdown of HDAC2 increases CD1d mRNA and surface expression, enhancing CD1d-mediated NKT cell antigen presentation; HDAC inhibitors enhance CD1d expression and NKT cell responses to lymphoma partially by relieving HDAC2-mediated repression of CD1D.\",\n      \"method\": \"ChIP of HDAC2 at CD1D promoter; HDAC2 siRNA knockdown; RT-PCR and flow cytometry for CD1d; NKT cell activation assays; HDAC inhibitor treatment\",\n      \"journal\": \"Cancer immunology, immunotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct chromatin occupancy by ChIP plus functional knockdown, single laboratory\",\n      \"pmids\": [\"27614429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CD1d controls the internalization of the lipid transporter CD36 in macrophages; CD1d-deficient macrophages show downregulation of lipid metabolic pathways and increased exogenous lipid import via CD36, priming macrophages for enhanced TLR-stimulated cytokine secretion; blocking CD36-mediated lipid uptake restores normal metabolic and immune responses in CD1d-KO macrophages.\",\n      \"method\": \"CD1d-KO macrophage transcriptomics/metabolomics; CD36 internalization assays; pharmacological CD36 blockade; TLR stimulation cytokine assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with pharmacological rescue plus multiple metabolic readouts, single laboratory\",\n      \"pmids\": [\"36344546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CD1d ligation on intestinal enterochromaffin (EC) cells activates protein tyrosine kinase Pyk2, which restrains potassium conductance, leading to calcium influx and peripheral serotonin (5-HT) secretion; inhibitory sphingolipids from Bacteroides fragilis repress this 5-HT release via the same CD1d pathway.\",\n      \"method\": \"iNKT cell–EC cell co-culture; CD1d-blocking antibodies; Pyk2 inhibition; calcium imaging; potassium channel assays; germ-free mouse experiments\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway (CD1d→Pyk2→K+ conductance→Ca2+ influx→5-HT) dissected with pharmacological tools, single laboratory\",\n      \"pmids\": [\"37354904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CEACAM5 physically interacts with CD1d through its B3 domain on intestinal epithelial cells; this interaction, together with CEACAM5–CD8α binding (requiring the N domain and its glycosylation), activates CD8-associated Lck and enables CD1d-mediated activation of CD8+ suppressor T cells.\",\n      \"method\": \"Co-immunoprecipitation; domain deletion mutants; N-domain deglycosylation; Lck activation assay; CD8+ T cell suppression assay\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-specific Co-IP and mutagenesis with functional signaling readout, single laboratory\",\n      \"pmids\": [\"24104458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Atypical NKT TCRs (TRAV21-TRAJ8-TRBV7-8 and TRAV12-3-TRAJ27-TRBV6-5) dock orthogonally over the A'-pocket of CD1d in a mode distinct from all type I NKT TCR–CD1d complexes, showing that diverse NKT TCR repertoire usage manifests in varied docking strategies and antigen specificities toward CD1d–α-GalCer.\",\n      \"method\": \"X-ray crystallography of atypical NKT TCR–CD1d–α-GalCer complexes; functional antigen reactivity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures of multiple ternary complexes with functional validation\",\n      \"pmids\": [\"26875526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Type II NKT TCR directed against the microbial antigen α-glucuronosyl-diacylglycerol (α-GlcADAG) adopts an F'-pocket docking mode on CD1d, contrasting sharply with the A'-roof positioning of sulfatide-reactive type II NKT TCRs, demonstrating that diverse type II NKT TCRs use multiple distinct recognition strategies on CD1d.\",\n      \"method\": \"X-ray crystallography of type II NKT TCR–CD1d–α-GlcADAG complex; functional antigen reactivity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure of ternary complex with functional validation, mechanistically distinct from prior structures\",\n      \"pmids\": [\"31748533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A TCR trap method capturing lipid antigens at the CD1d–TCR interface identified α-linked monohexosylceramides from cow's milk as endogenous iNKT cell antigens, directly biochemically proving α-anomeric lipid antigens from a common dietary source occupy the CD1d–TCR interface.\",\n      \"method\": \"CD1d-lipid-TCR complex capture (TCR trap); mass spectrometry fragmentation distinguishing α- from β-anomeric monohexosylceramides\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — novel direct biochemical antigen capture method with MS identification, single laboratory\",\n      \"pmids\": [\"28716901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CD1d-lipid presentation by regulatory B cells (Bregs) drives iNKT cells to secrete IFN-γ, which contributes to downregulation of Th1 and Th17 responses and amelioration of experimental arthritis; mice lacking CD1d-expressing B cells fail to respond to α-GalCer treatment, and loss of B cell CD1d alters iNKT cell metabolic and cytokine regulation.\",\n      \"method\": \"Chimeric mice; B cell depletion and adoptive cell transfer; CD1d-conditional B cell-specific knockout; experimental arthritis model; cytokine and metabolic assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic/cell transfer approaches with functional immune and disease readouts, single laboratory\",\n      \"pmids\": [\"29449556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Amine headgroups of ionizable lipids in lipid nanoparticles directly bind to CD1d (and TLR4) and promote lipid-raft formation, driving LNP immunogenicity; these inflammatory signals inhibit anti-PEG IgM production, preventing loss of LNP efficacy on repeated dosing.\",\n      \"method\": \"Direct binding assays (CD1d and TLR4); lipid raft formation assays; immunoglobulin isotype profiling; cytokine measurement; structure-activity analysis of ionizable lipid headgroups\",\n      \"journal\": \"Nature biomedical engineering\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding demonstrated plus functional immune readouts, single laboratory\",\n      \"pmids\": [\"39363106\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD1d is a non-polymorphic MHC class I-like molecule that presents lipid and glycolipid antigens (loaded in the ER by MTP and in endosomes by saposins) to NKT cells via a conserved parallel/orthogonal TCR docking mode; its cytoplasmic tail mediates ubiquitin-dependent endocytosis (exploited by pathogens), JAK2-STAT3 anti-apoptotic signaling in hepatocytes, and Pyk2-dependent serotonin secretion in enterochromaffin cells, while its surface expression is regulated transcriptionally by PPARγ/RARα/retinoic acid, IFN-γ, miR-155/Ets-1, and HDAC2, and post-translationally by ER stress and β2-microglobulin-dependent glycan maturation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CD1d is a non-polymorphic MHC class I-like antigen-presenting molecule that loads lipid and glycolipid antigens and displays them at the cell surface to NKT cells, governing innate-like T cell immunity at barrier and lymphoid sites [#0, #4]. Maturation and trafficking of CD1d depend on β2-microglobulin, which is required for Golgi transit and acquisition of endoglycosidase-H-resistant mature glycosylation [#11]. Antigen loading is orchestrated in the ER by microsomal triglyceride transfer protein (MTP), which associates with CD1d and directly transfers phospholipids onto nascent molecules, a step required for presentation of both exogenous α-galactosylceramide and endogenous lipids [#2, #3]. The CD1d groove accommodates a broad spectrum of lipids — glycosphingolipids, phosphatidylinositol, cardiolipin, lysophosphatidylcholine, sphingomyelin, and dietary α-linked monohexosylceramides — with the presented species and its conformation dictating recognition outcomes [#4, #5, #6, #7, #22, #31]. Structural studies establish that type I (invariant) NKT TCRs dock parallel at the extreme end of the cleft via conserved germline-encoded α-chain contacts, while autoreactivity is conferred by a hydrophobic CDR3β motif; γδ and atypical/type II NKT TCRs instead engage CD1d orthogonally over the A' or F' pockets, defining a repertoire of distinct docking strategies [#0, #1, #5, #29, #30]. Beyond antigen display, the CD1d cytoplasmic tail transduces intrinsic signals: tail tyrosine phosphorylation recruits JAK2 to activate STAT3 and anti-apoptotic effectors protecting hepatocytes, epithelial CD1d engagement drives a protective STAT3→IL-10 axis whose loss causes NKT-mediated colitis, and in enterochromaffin cells CD1d ligation activates Pyk2 to trigger serotonin secretion [#16, #19, #27]. CD1d surface levels are controlled transcriptionally and post-transcriptionally by retinoic acid/RARα and PPARγ, IFN-γ, miR-155/Ets-1, and HDAC2, and post-translationally by ER stress and ubiquitin-dependent endocytosis, the latter exploited by KSHV MIR proteins and HIV-1 Nef to evade NKT surveillance [#8, #9, #10, #13, #16, #24, #25].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that CD1d expression is inducible, showing IFN-γ drives CD1d mRNA and surface protein on intestinal epithelium and linking the molecule to inflammatory regulation.\",\n      \"evidence\": \"Whole-cell ELISA and RT-PCR across epithelial cell lines with cytokine specificity controls\",\n      \"pmids\": [\"8760056\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify the transcription factors mediating induction\", \"No NKT functional readout linked to the increased expression\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined the biosynthetic and localization requirements of CD1d, showing β2m association is required for Golgi transit and mature glycosylation while β2m-independent immature forms reach the surface, particularly apically in epithelium.\",\n      \"evidence\": \"Pulse-chase metabolic labeling, endo-H/N-glycanase digestion, surface biotinylation, and confocal microscopy in transfected and epithelial cells\",\n      \"pmids\": [\"10092605\", \"10221650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of the β2m-independent apical form for antigen presentation unresolved\", \"Did not address lipid loading along this trafficking route\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Provided the first quantitative biophysical proof that CD1d directly binds glycolipid antigen, establishing it as a lipid-binding presentation molecule with broad ligand capacity.\",\n      \"evidence\": \"Surface plasmon resonance and plate-bound presentation assays with purified recombinant soluble CD1d\",\n      \"pmids\": [\"10523605\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the structural basis of TCR engagement\", \"Loading mechanism in cells not addressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Enabled direct detection of antigen-specific NKT cells by reconstituting functional CD1d-glycolipid tetramers, providing a tool that anchored subsequent functional and clinical studies.\",\n      \"evidence\": \"Oxidative refolding chromatography of denatured CD1d/β2m with synthetic lipids and ex vivo tetramer staining\",\n      \"pmids\": [\"11248072\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Methodological advance rather than mechanistic insight into CD1d biology\", \"Single laboratory\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified the ER chaperone that loads CD1d, showing MTP associates with CD1d and directly transfers phospholipids onto it, a step required in vivo for NKT activation.\",\n      \"evidence\": \"Reciprocal Co-IP, hepatocyte-specific Mttp knockout, siRNA, and in vitro lipid transfer with purified MTP and recombinant CD1d\",\n      \"pmids\": [\"15107843\", \"16087713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MTP-loaded endogenous lipids are exchanged for antigenic lipids in endosomes not defined\", \"Selectivity for phospholipids over other ER lipids incompletely mapped\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Revealed the CD1d cytoplasmic tail as a target of pathogen immune evasion, with KSHV MIR proteins ubiquitinating a tail lysine to trigger endocytosis and HIV-1 Nef binding the tail to downregulate surface CD1d.\",\n      \"evidence\": \"Ubiquitination and endocytosis assays, Co-IP, and cytoplasmic tail mutant/deletion constructs with NKT activation readouts\",\n      \"pmids\": [\"15864354\", \"15916790\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nef interaction shown in a single laboratory without reciprocal validation in infection\", \"Endogenous host machinery that normally uses this endocytosis signal not fully identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established retinoic acid signaling as a direct transcriptional control of CD1d, with PPARγ acting upstream through ATRA synthesis and RARα directly driving CD1d expression in dendritic cells and B cells.\",\n      \"evidence\": \"Pharmacological PPARγ/RARα modulation, enzyme assays, and iNKT co-culture in human DCs and B cells\",\n      \"pmids\": [\"16982809\", \"21451111\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct RARα occupancy of the CD1D promoter not shown structurally\", \"Single laboratory for each cell type\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved the molecular docking mode of the canonical NKT TCR, showing parallel binding at the cleft end with conserved germline α-chain contacts to the CD1d-antigen complex.\",\n      \"evidence\": \"X-ray crystallography of the NKT TCR–CD1d–α-GalCer ternary complex\",\n      \"pmids\": [\"17581592\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not explain recognition of self versus foreign lipids\", \"Limited to a single TCR/antigen pair\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Linked organelle stress to CD1d function, showing ER stress in steatotic hepatocytes impairs CD1d trafficking and depletes liver NKT cells despite normal mRNA.\",\n      \"evidence\": \"Subcellular fractionation, surface flow cytometry, and T cell activation in ob/ob and tunicamycin-treated mice\",\n      \"pmids\": [\"17607300\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular checkpoint coupling the UPR to CD1d export not identified\", \"Single laboratory\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Explained the structural basis of NKT autoreactivity and broadened the lipidome CD1d can present, showing a CDR3β hydrophobic motif drives self-recognition and that cardiolipin loading stimulates γδ T cells.\",\n      \"evidence\": \"High-resolution crystal structures of NKT TCR–PI–CD1d and CD1d–cardiolipin complexes with functional T cell assays\",\n      \"pmids\": [\"21376640\", \"21389252\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological abundance of these self-lipids on CD1d not quantified\", \"γδ recognition of cardiolipin structurally inferred rather than co-crystallized\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated antigen-induced conformational plasticity of CD1d, with lysophosphatidylcholine opening the A' pocket and TCR binding enforcing headgroup displacement and a closed conformation.\",\n      \"evidence\": \"Crystal structures of CD1d–LPC and the iNKT TCR ternary complex with functional iNKT assays\",\n      \"pmids\": [\"22395072\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of induced-fit recognition across other lysolipids not established\", \"Single antigen-TCR pair\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Expanded the CD1d-restricted TCR universe, showing a Vδ1 γδ TCR docks orthogonally over the A' pocket using germline CDR1δ, distinct from invariant NKT recognition.\",\n      \"evidence\": \"X-ray crystallography of a γδ TCR–CD1d–α-GalCer complex with primary γδ T cell functional assays\",\n      \"pmids\": [\"24076636\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo antigens driving γδ recognition of CD1d not defined\", \"Single TCR studied\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified a co-receptor partnership for epithelial CD1d, showing CEACAM5 binds CD1d via its B3 domain and bridges CD8α to activate Lck and CD8+ suppressor T cells.\",\n      \"evidence\": \"Domain-mapped Co-IP, deglycosylation mutants, and Lck activation/suppression assays in intestinal epithelium\",\n      \"pmids\": [\"24104458\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single laboratory without reciprocal in vivo validation\", \"Lipid antigen requirement for this CD8+ T cell activation unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established intrinsic epithelial CD1d signaling as protective, defining a CD1d→STAT3→IL-10/HSP110 axis whose loss causes NKT-mediated colitis.\",\n      \"evidence\": \"IEC-specific conditional deletion of CD1d, MTP, IL-10, and HSP110 with STAT3 assays, colitis models, and bone marrow chimeras\",\n      \"pmids\": [\"24717441\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream ligand triggering epithelial CD1d signaling in vivo not defined\", \"Connection to the tail tyrosine signaling described later not yet integrated\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined post-transcriptional and transcriptional repression of CD1d on B cells, with TLR9-induced miR-155 targeting the CD1D 3'-UTR and Ets-1 directly regulating transcription, with relevance to SLE.\",\n      \"evidence\": \"3'-UTR luciferase reporters, miR-155 gain/loss, Ets-1 binding analysis, and iNKT activation assays\",\n      \"pmids\": [\"25929465\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contributions of miR-155 versus Ets-1 in vivo not quantified\", \"Single laboratory\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified chromatin-level control of CD1d, showing HDAC2 occupies the CD1D promoter and represses expression, with HDAC inhibition enhancing NKT responses against lymphoma.\",\n      \"evidence\": \"ChIP at the CD1D promoter, HDAC2 siRNA, and NKT activation/HDAC inhibitor assays\",\n      \"pmids\": [\"27614429\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Histone marks and co-repressors at the locus not mapped\", \"Single laboratory\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed that diverse NKT TCR repertoire usage manifests as varied docking geometries, with atypical NKT TCRs engaging CD1d orthogonally over the A' pocket.\",\n      \"evidence\": \"Crystal structures of multiple atypical NKT TCR–CD1d–α-GalCer complexes with antigen reactivity assays\",\n      \"pmids\": [\"26875526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional significance of docking diversity for in vivo selection not resolved\", \"Limited number of TCRs sampled\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Linked hepatocyte CD1d to liver iNKT homeostasis, showing hepatocyte-specific loss of MTP or CD1d increases liver iNKT numbers through altered iNKT apoptosis, and biochemically captured a dietary α-anomeric antigen at the CD1d–TCR interface.\",\n      \"evidence\": \"Conditional hepatocyte MTP/CD1d knockouts with apoptosis/hepatitis models, and TCR-trap capture with mass spectrometry of milk monohexosylceramides\",\n      \"pmids\": [\"28893990\", \"28716901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which hepatocyte CD1d controls iNKT apoptosis not molecularly defined\", \"Antigen capture from a single laboratory\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated a regulatory immune function for B cell CD1d, showing Breg CD1d-lipid presentation drives iNKT IFN-γ to dampen Th1/Th17 responses and ameliorate arthritis.\",\n      \"evidence\": \"B cell-conditional CD1d knockout, chimeras, adoptive transfer, and experimental arthritis with cytokine/metabolic assays\",\n      \"pmids\": [\"29449556\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous lipid antigen presented by Bregs not identified\", \"Single laboratory\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified sphingomyelin as a non-activating CD1d ligand whose accumulation impairs antigen presentation, linking acid sphingomyelinase to thymic iNKT selection, and structurally diversified type II NKT recognition via an F'-pocket docking mode.\",\n      \"evidence\": \"ASM-deficient mouse/human (Niemann-Pick) studies with pharmacological rescue, plus crystallography of a type II NKT TCR–CD1d–α-GlcADAG complex\",\n      \"pmids\": [\"31636468\", \"31748533\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How sphingomyelin is normally turned over to permit antigen loading in vivo incompletely defined\", \"Breadth of type II recognition modes not exhausted\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Uncovered a metabolic regulatory role for CD1d in macrophages, controlling CD36 internalization to limit lipid import and restrain TLR-driven cytokine secretion.\",\n      \"evidence\": \"CD1d-KO macrophage transcriptomics/metabolomics, CD36 internalization assays, and pharmacological CD36 blockade rescue\",\n      \"pmids\": [\"36344546\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between CD1d and CD36 trafficking not defined\", \"Single laboratory\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined intrinsic CD1d tail signaling pathways, showing tail tyrosine phosphorylation recruits JAK2 to activate STAT3 anti-apoptotic signaling in hepatocytes, and CD1d ligation activates Pyk2 to drive serotonin secretion from enterochromaffin cells.\",\n      \"evidence\": \"Hepatocyte CD1d gain/loss with crosslinking and JAK2/STAT3 assays in lipotoxicity/liver injury models; iNKT–EC co-culture with Pyk2 inhibition, calcium imaging, and germ-free mice\",\n      \"pmids\": [\"38438948\", \"37354904\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological ligand triggering hepatocyte CD1d phosphorylation not identified\", \"Both mechanisms from single laboratories\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended CD1d ligand recognition to synthetic lipids, showing ionizable lipid amine headgroups in nanoparticles bind CD1d and promote lipid-raft-driven immunogenicity that suppresses anti-PEG IgM.\",\n      \"evidence\": \"Direct binding assays, lipid raft and cytokine measurements, and structure-activity analysis of ionizable lipid headgroups\",\n      \"pmids\": [\"39363106\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural mode of ionizable lipid binding to CD1d not resolved\", \"Single laboratory\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the distinct CD1d cytoplasmic-tail signaling modules (ubiquitin-dependent endocytosis, JAK2-STAT3, Pyk2) are integrated, what physiological ligands trigger them, and how lipid loading is coordinated across ER and endosomal compartments remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking tail tyrosine phosphorylation events to downstream effectors across cell types\", \"Endogenous physiological triggers of CD1d intrinsic signaling unknown\", \"In vivo lipid exchange machinery downstream of MTP not fully mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [3, 4, 5, 6, 7, 22, 31, 33]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [16, 19, 27, 20]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [16, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 9, 11, 12, 17]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 3, 17]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 2, 16, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [16, 19, 27]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [18, 19, 20]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"B2M\", \"MTTP\", \"JAK2\", \"CEACAM5\", \"Nef\", \"MIR2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":7,"faith_pct":85.71428571428571}}